Mettler-Toledo International, Inc.

Mettler-Toledo International, Inc.

MTD

Get informed when a big investor buys or sells

+ Follow
Market Cap$23.86B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Mettler-Toledo International, Inc.Mettler-Toledo International, Inc.27.4--2089%5.8-53.2

Earnings Call Q1 2026

May 8, 2026 - AI Summary

Q1 performance: solid growth despite uncertainty - Sales: $947m, +3% local currency (+1% excluding acquisitions), +7% reported FX basis; acquisitions contributed ~1.5%. - By product: Laboratory +1% LC (bioprocessing strong; pipettes down due to weaker academia/biotech), Industrial +5% LC (core industrial +1%, product inspection +11%), Food Retail +7%, Service +7% (+5% ex-acquisitions). - Profitability: gross margin 58.7% (-80 bps YoY) but +10 bps ex-FX/acquisitions; offset by supply chain/pricing vs incremental tariff headwind ~90 bps. - Earnings: Adjusted EPS $8.91 (+9% YoY); tariff impact ~4% gross EPS headwind. Reported EPS $8.33 (includes purchased intangibles, restructuring, and timing effects). - Cash: Adjusted free cash flow $120m, impacted by tax timing (+$58m vs prior year); DSO 35 days, ITO 4.2x.
Full-year guidance: reiterated sales growth; EPS growth maintained/raised slightly - 2026 local-currency sales growth ~4% (acquisitions ~1.5% in 1H, <1% full year). Implication: organic growth slightly softer than earlier assumptions due to macro caution. - Adjusted EPS forecast: $46.30–$46.95, +8% to +10% YoY (notable: raised from prior 8–9%). - FX: ~2% FX benefit to sales growth, neutral to EPS at current spot rates. - Q2 expectations: local-currency sales ~+3% including ~+1.5% acquisitions; adjusted EPS $10.70–$10.85 (+6% to +8% YoY).
Margin/cost outlook: tariffs + inflation are the main headwinds; pricing helps - 2026 assumes tariff environment: guidance includes Feb U.S. import tariff-rate benefit but assumes tariffs in 2H revert to prior IEEPA levels. - They did not include potential tariff refunds (for the company: could reduce COGS; for customers: could reduce sales)—and will exclude these from adjusted EPS/organic growth in future periods. - Cost pressure expected: inflation linked to Middle East war; management expects cost savings + pricing actions to mitigate. - Price environment commentary: Q1 pricing ~3.5%, Q2 ~2.5% (maybe slightly better), and 2H normalized ~2% for full-year.

Exclusive for Stockcircle Pro members

Sign upSign Up
$1402.80

Target Price by Analysts

20% upsideMettler-Toledo International Target Price DetailsTarget Price
$618.75

Current Fair Value

47.1% downside

Overvalued by 47.1% based on the discounted cash flow analysis.

Share Statistics

Market cap$23.86 Billion
Enterprise Value$26.02 Billion
Dividend Yield$- (-)
Earnings per Share$42.17
Beta1.31
Outstanding Shares20,286,133

Return

Return on Equity-2089.30%ROE
Return on Assets23.85%
Return on Invested Capital44.72%

Valuation & Multiples

P/E Ratio27.37P/E Ratio
PEG763.11PEG
Price to Sales5.82Price to Sales
Price to Book Ratio-389.77Price to Book Ratio
Enterprise Value to Revenue6.36
Enterprise Value to EBIT22.73
Enterprise Value to Net Income29
Total Debt to Enterprise0.09
Debt to Equity-53.21Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 7, 2026
EPS Estimate
$8.71
Average shareholder expectation
Revenue Estimate
$943.14 M
Average shareholder expectation

Next Earnings Call

Expected Date
July 30, 2026
EPS Estimate
$10.78
Average shareholder expectation
Revenue Estimate
$1.03 B
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.1808▲ 2.67%
Total Calls220,600▼ 2.04%
Total Puts39,876▲ 14.92%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %96.30%▼ 3.13%
Total Invested$25.14B▼ 11.00%
Investors Holding829▼ 33.00%

ESG Score

No data

About Mettler-Toledo International, Inc.

CEO: Oliver Filliol

Relevant Senate Committees

Joint Committee on Taxation

By providing official revenue estimates and influencing corporate tax structures and capital investment credits, this committee directly impacts MTD's financial planning and profitability.

Finance

Controlling taxation and trade policy, this committee directly impacts MTD's profitability, international competitiveness through tariffs, and overall corporate valuation.

Appropriations

This committee allocates federal spending, directly determining funding for scientific research, academic institutions, and federal agencies that are key purchasers of MTD's analytical instruments.

Health, Education, Labor, and Pensions

This committee regulates the FDA and NIH, directly impacting the pharmaceutical and biotech sectors which are major users of MTD's laboratory instruments for R&D and quality control.

Foreign Relations

As 'Mettler-Toledo International,' global trade, sanctions, and foreign policy directly affect MTD's international sales, supply chains, and overall business environment.